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Understanding viral dynamics in arthropods is of great importance when designing models to describe how viral spread can in-
fluence arthropod populations. The endosymbiotic bacteriumWolbachia spp., which is present in up to 40% of all insect species,
has the ability to alter viral dynamics in bothDrosophila spp. andmosquitoes, a feature that in mosquitoes may be utilized to
limit spread of important arboviruses. To understand the potential effect ofWolbachia on viral dynamics in nature, it is impor-
tant to consider the impact of natural routes of virus infection onWolbachia antiviral effects. Using adultDrosophila strains, we
show here thatDrosophila-Wolbachia associations that have previously been shown to confer antiviral protection following sys-
temic viral infection also confer protection against virus-inducedmortality following oral exposure to Drosophila C virus in
adults. Interestingly, a different pattern was observed when the same fly lines were challenged with the virus when still larvae.
Analysis of the fourDrosophila-Wolbachia associations that were protective in adults indicated that only the w1118-wMelPop
association conferred protection in larvae following oral delivery of the virus. Analysis ofWolbachia density using quantitative
PCR (qPCR) showed that a highWolbachia density was congruent with antiviral protection in both adults and larvae. This study
indicates thatWolbachia-mediated protectionmay vary between larval and adult stages of a givenWolbachia-host combination
and that the variations in susceptibility by life stage correspond withWolbachia density. The differences in the outcome of virus
infection are likely to influence viral dynamics inWolbachia-infected insect populations in nature and could also have important
implications for the transmission of arboviruses in mosquito populations.
Arthropods harbor a wide range of viruses that can be trans-mitted between individuals or populations of the same spe-
cies or can bridge the interspecies gap to infect plants or other
animals. The outcome of viral infections can be modulated by
tripartite interactions between arthropods, viruses, and bacteria
(1). One such interaction is the tripartite interaction between in-
sects, viruses, and the endosymbyotic bacterium Wolbachia pipi-
entis.
Wolbachia spp. have gainedmuch attention due to the antiviral
effects they confer to their host. The impact of Wolbachia spp. on
virus infection was first described in the Drosophila melanogaster
host, where it was shown to protect against mortality induced by
diverse viruses, including Drosophila C virus (DCV), cricket pa-
ralysis virus, and Flock House virus (2, 3). Since that discovery,
Wolbachia-mediated antiviral effects have been demonstrated in a
number of insect hosts and are being investigated as a way of
limiting spread of arboviruses (reviewed in references 1, 4, 5, and
6). Notably,Wolbachia-mediated antiviral effects have been dem-
onstrated in adult mosquitoes artificially infected withWolbachia;
in mosquitoes, Wolbachia can interfere with accumulation and
transmission of important human pathogens, including dengue
and Chikungunya viruses (7–17). While in many casesWolbachia
confers antiviral effects to its host organism, in some cases the
presence of Wolbachia can enhance viral susceptibility (18–23).
The impact of the presence of Wolbachia on virus infection can
include two main effects: (i) interference with viral replication/
accumulation, and/or (ii) protection against virus-induced mor-
tality. In mosquitoes, Wolbachia interferes with viral replication/
accumulation, while in Drosophila, Wolbachia can interfere with
viral replication/accumulation and/or protect flies from virus-in-
ducedmortality. In this paper, we focus on the effect ofWolbachia
on the survival of the host, and we define protection as a reduc-
tion/delay in virus-induced mortality.
The mechanisms involved inWolbachia-mediated antiviral ef-
fects have not yet been fully elucidated. There is some evidence
that microRNAs (24, 25), competition for host-derived re-
sources (26), and elevated reactive oxygen species (27, 28) may
influence antiviral effects. Drosophila-Wolbachia associations
can be subdivided into two groups: protective and nonprotec-
tive. The Drosophila-Wolbachia pairings CO-wAu, DSR-wRi,
w1118-wMel, and the overreplicating and life-shortening
w1118-wMelPop association all show a delay in DCV-induced
mortality when DCV is injected into adult flies, while the
N7NO-wNo and DSH-wHa combinations did not (2, 3, 11,
29). A feature that all protective Wolbachia strains share is high
density within their respective host organism, indicating that high
Wolbachia density may serve as a prerequisite for antiviral protec-
tion (7, 12, 29–34).
Wolbachia is estimated to infect 40% of all insects (35);
therefore, the effect it exerts on natural viral dynamics could be
pronounced. The understanding of natural tripartite Drosoph-
ila-virus-Wolbachia interactions is very limited at present, par-
tially due to a lack of a method for orally delivering the virus.
Recently, three methods for oral infection of larvae and adults
were described, and these will allow us to study the effects of the
Received 1 September 2015 Accepted 16 September 2015
Accepted manuscript posted online 25 September 2015
Citation Stevanovic AL, Arnold PA, Johnson KN. 2015.Wolbachia-mediated
antiviral protection in Drosophila larvae and adults following oral infection. Appl
Environ Microbiol 81:8215–8223. doi:10.1128/AEM.02841-15.
Editor: H. Goodrich-Blair
Address correspondence to Karyn N. Johnson, karynj@uq.edu.au.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
December 2015 Volume 81 Number 23 aem.asm.org 8215Applied and Environmental Microbiology
 o
n
 N
ovem
ber 16, 2015 by UQ Library
http://aem
.asm
.org/
D
ow
nloaded from
 
oral route of infection on antiviral protection mechanisms in
Drosophila (36–38).
To investigate the effects of Wolbachia on virus-induced mor-
tality following oral infection, we used DCV, a naturalDrosophila
pathogen and the most widely studied Drosophila virus (39).
DCV is a positive-sense RNA virus that belongs to theDicistroviri-
dae family (40).When injected into flies,DCV is pathogenic, caus-
ing mortality within 4 to 6 days postinjection (41). Injection of
DCV is a useful method to study Wolbachia-DCV interactions;
however, injection bypasses the fly’s natural immune barriers
present within the midgut and can cause a differential immune
response compared to exposure via virus feeding alone (37). DCV
infection by ingestion is less pathogenic than by injection (36, 37)
and represents amore naturalDrosophila-DCV interaction.While
Wolbachia-mediated protection has been extensively studied in
adult flies following a systemic infection, it is not yet clear whether
the Drosophila-Wolbachia associations that are protective for vi-
rus-induced host mortality following viral injection also exhibit a
similar protective characteristic following the oral route of infec-
tion. Ingestion of infected cadavers is thought to be one of the
mechanisms through which DCV transmission occurs naturally
within an insect population (42); therefore, Wolbachia-mediated
antiviral protection following the oral route of infection could
have a direct impact on viral transmission andmaintenance of the
virus within a population.
Understanding the potential of Wolbachia to affect viral dy-
namics in natural populations will be facilitated by insights into
the impact of antiviral protection on susceptibility throughout the
life cycle of the host, following exposure via a natural route of
infection. Both Drosophila and mosquitoes are holometabolous
insects, as they undergo metamorphosis between the larval and
adult stages. A wide range of genes coordinate the disintegration
of larval structures, where some larval organs are histolyzed and
major new growth takes place, altering the morphology and in
some cases pathogen susceptibility (43–45). Pathogen susceptibil-
ity is often age or life stage dependent and can have a large effect on
population dynamics, viral spread, and maintenance of the virus
within the population (45–48). Studies focusing on the antiviral
effects of Wolbachia have to date been conducted solely on adult
flies andmosquitoes, without consideration of other developmen-
tal stages.
Here, we investigated the effect ofWolbachia on virus-induced
mortality of Drosophila larvae and adults following oral challenge
with DCV. By using four Drosophila-Wolbachia associations that
have previously been shown to be protective for adult insects fol-
lowing viral injection, we show that theDrosophila-Wolbachia as-
sociations that are protective against virus-induced mortality fol-
lowing injection are also protective following oral infection of
adults. In contrast,Wolbachia protection at the adult stages is not
indicative of protection at larval stages, as only one out of four
Drosophila-Wolbachia associations that were protective at the
adult stage showed protection at the larval stage.
MATERIALS AND METHODS
Drosophila andWolbachia. TwoDrosophila melanogaster and threeDro-
sophila simulans fly lines were reared on a standard cornmealmedium at a
constant temperature of 25°Cwith a 12-hour light/dark cycle. Paired pop-
ulations of flies were used that either containedWolbachia (w1118-wMel,
w1118-wMelPop, N7NO-wNo, DSR-wRi, and Co-wAu) or had been
cured of Wolbachia by tetracycline treatment (w1118-T, N7NO-T,
DSR-T, and CO-T); flies were maintained on a standard cornmeal me-
dium for at least five generations before use. Gut flora was reconstituted
and normalized across fly lines by using standardized methods (31).
Briefly,Drosophila embryos were transferred to vials containing 150l of
a bacterial inoculum, which was prepared by adding 2 g of 10-day-old
food containing w1118-wMelPop flies to 5ml of sterile water and strained
through a fine sterile mesh to remove larvae and embryos. The newly
treated flies were checked for the presence ofWolbachia by using PCR, to
make sure that no cross-contamination had occurred.
Virus. Plaque-purified DCV isolate EB (49, 50) was propagated and
purified from Schneider’sDrosophila line 2 cells (51), and virus titers were
determined based on the 50% tissue culture infective dose (TCID50), as
described previously (29, 49).
DNAextraction.Thirty 0- to 4-h-old larvae or 10 newly emergedmale
adult flies were pooled to performDNA extraction. The flies were homog-
enized using a pestle in 180l of extraction buffer and 20l of proteinase
K. The DNeasy blood and tissue kit (Qiagen) was used to extract the DNA
as per the manufacturer’s protocol. Three replicates on independent co-
horts were performed for each treatment.
Quantitative PCR. The abundance of Wolbachia was assessed by
quantitative PCR (qPCR) to determine the abundance of the Wolbachia
surface protein gene (wsp) relative to that of either the D. melanogaster
RrpL32 or D. simulans Act5C genes. Platinum SYBR green qPCR Super-
Mix-UDG(Invitrogen)was used per themanufacturer’s instruction using
the wsp-specific primer pair 5=-GCATTTGGTTAYAAAATGGACGA-3=
and 5=-GGAGTGATAGGCATATCTTCAAT-3= (producing a 185-bp
PCR product) (29), RpL32-specific primers 5=-GACGCTTCAAGGGAC
AGTATCTG-3= and 5=-AAACGCGGTTCTGCATGAG-3= (producing a
141-bp PCR product) (49), and Act5C-specific primers 5=-GACGAAGA
AGTTGCTGCTCTGGTTG-3= and 5=-TGAGGATACCACGCTTGCTCT
GC-3= (producing a 192-bp PCR product) (30). The Rotor-Gene 6000
thermal cycler (Corbett Life Sciences,Qiagen)was usedwith the following
profile: 95°C for 2 min, followed by 40 cycles of 95°C for 10 s, 52°C for 10
s, and 72°C for 20 s. This was followed by a standardmelt analysis to assess
the specificity of the amplified product. Two technical replicates (separate
qPCRs on the same DNA) were performed for each sample (with a third
performed where necessary), and DNA extracted from flies without
Wolbachia was used as a negative control. Mean normalized wsp:RpL32
DNA ratios were calculated using qGENE software (52), and statistical
analysis included a two-tailed Student’s t test to compare differences of the
means.
Survival bioassay. Virus for larval and adult feeding assays was
prepared by injecting flies with either 5,000 infectious units (IU) of
DCV or an equivalent volume of phosphate-buffered saline (PBS),
which acted as a control. Live flies were collected at 4 days postinjec-
tion and stored at 20°C until further use. Thirty PBS- or DCV-
injected flies were pooled and homogenized in 300 l of PBS, and the
supernatant was filter sterilized using a Millex GV 22-mfilter (Merck
Millipore). Homogenates prepared in this way were used for both
adult and larval bioassays. The titers for DCV-injected fly homoge-
nates were measured on four occasions and ranged between 4.4 1010
and 2  1011 IU/ml.
For adult infections, a modified version of a previously described
method was used (37). A mix (250-l volume) containing 75% fly
homogenate (DCV or PBS treated, as described above) and 25% dry
yeast was applied to a 1.5- by 1.5-cm filter paper and placed in a vial
containing 10 4- to 7-day-old male flies. Flies were incubated with the
medium for 24 h at 25°C with high humidity to prevent the food from
drying out. Following this period, the flies were transferred to standard
cornmeal medium, and mortality was scored daily for 15 days. Three
replicates of independent cohorts were performed for each treatment.
Larval infections were performed by spreading DCV- or mock-
infected fly homogenates onto petri dishes containing 10 ml of stan-
dard cornmeal medium (36). One hundred eggs were collected for
each treatment on a wet piece of sterile filter paper and transferred
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onto petri dishes containing homogenates from either PBS- or DCV-
injected flies. Larvae were maintained on the treatment medium until
adult emergence, and they were counted 3 days postemergence. Egg-
to-adult survival was determined as the proportion of adults poste-
mergence relative to the initial number of eggs at the start of the
treatment, and each survival bioassay was replicated 3 times with in-
dependent cohorts of insects.
Statistical analysis of the survival bioassay results. We used gener-
alized linear mixed-effects regression (GLMER) models based on a
binomial distribution to examine the effect of feeding treatment and
coinfection on the mortality of five D. melanogaster and D. simulans
larvae, and we employed the lme4 R package in R 2.15.3 (53) (R Foun-
dation for Statistical Computing, Vienna, Austria). The mortality re-
sponse, as the binomial count of flies that survived or died for each
line, was determined by fitting the feeding treatment (PBS or DCV)
and coinfection treatment (absence of Wolbachia [-wol] or with a
Wolbachia strain), as well as the interaction between the two factors. The
interaction term compared across themortality values of each of the feed-
ing treatments across the absence (wol) or presence ( indicated
Wolbachia strain) of Wolbachia. Each model included an experimental
replicate as a random factor for analysis of the replicate variance compo-
nent in each model. For adult survival bioassays, the survival curves were
compared using Kaplan-Meier analysis and log rank statistics within the
GraphPad Prism program.
RESULTS
Wolbachia protection in adult flies following oral challenge
with DCV. Initially, we tested the protective effects of theWolba-
chia strainwAu in a COfly background (CO-wAu) due to a strong
antiviral protection observed previously following systemic DCV
infection (29). Wolbachia-free CO flies challenged with DCV by
oral infection showed 40% mortality within 15 days postfeeding.
In contrast, CO-wAu flies showed a significant reduction in mor-
tality during the same time period, to 7% (Fig. 1A; Kaplan-Meyer
analysis, P 0.05). We investigated an additional three Drosoph-
ila-Wolbachia associations, DSR-wRi, w1118-wMel, and w1118-
wMelPop, all of which have previously been shown to confer pro-
tection against DCV-induced mortality in adult flies following a
systemic infection (3, 29, 49), and the results indicated that all
three Drosophila-Wolbachia associations conferred protection
against DCV-induced mortality following the oral route of infec-
tion (Fig. 1B, D, and E; Kaplan-Meyer analysis, P 0.05). Because
not allDrosophila-Wolbachia associations protect against systemic
viral infections, we tested a nonprotective association, N7NO-
wNo, to see whether protection would occur following oral virus
challenge (29). Feeding the nonprotective N7NO-wNo flies with
DCV led to a nonsignificant difference in virus-inducedmortality
compared toWolbachia-free flies (Fig. 1C; Kaplan-Meyer analysis,
P 0.05). Taken together, these results indicate that Wolbachia-
mediated protection against virus-induced mortality in adults in-
fected through the oral route was consistent with what was previ-
ously reported following injection of virus.
Wolbachiaprotection in larvae followingoral challengewith
DCV. To determine whether exposure to Wolbachia sp. protects
larvae from virus-induced mortality, we orally challenged CO-
wAu larvae with DCV. We found that inWolbachia-free flies, lar-
vum-to-adult mortality increased from about 37% in mock-in-
fected flies to about 46% in DCV-infected flies and that the
presence of Wolbachia had no significant effect on DCV-induced
mortality (Fig. 2A and Table 1). This suggests that the Wolbachia
strainwAumay not protect its host against DCV-inducedmortal-
ity following this route of infection at the larval developmental
stages.
As no protection was observed in CO-wAu larvae, we then
investigated whether the lack of protection was specific to this
Drosophila-Wolbachia association. We investigated other protec-
tive Drosophila-Wolbachia associations, DSR-wRi and w1118-
wMel, and one nonprotective association, N7NO-wNo. None of
these associations showed a significant difference in DCV-in-
duced mortality between larvae with and withoutWolbachia (Fig.
2B to D and Table 1), suggesting that the lack of Wolbachia-me-
diated protection at the larval stages is not confined to CO-wAu
flies.
TheWolbachia strainwMelPop has a strong protective effect in
both adult flies and mosquitoes, so we investigated whether
w1118-wMelPop larvae exhibited a protective phenotype. In this
Drosophila-Wolbachia association, there was a statistically signifi-
cant difference in DCV-induced mortality between flies with and
withoutWolbachia (25%and 37%mortality, respectively) (Fig. 2E
andTable 1). Unlike the otherDrosophila-Wolbachia associations,
wMelPop provided complete protection against DCV-induced
mortality (Fig. 2E). Because the ability to confer antiviral effects is
strongly associated withWolbachia density in adult flies andmos-
quitoes and because wMelPop is known to be an overreplicative
strain, we investigatedwhether the observed differences inWolba-
chiaprotectionwere associatedwith differences inWolbachiaden-
sities.
Wolbachia densities. Wolbachia densities have previously
been determined in adults but not in larvae for differentDrosoph-
ila-Wolbachia associations. Using qPCR, we determined Wolba-
chia densities at both the larval and adult stages for all five Dro-
sophila-Wolbachia associations used in this study (Fig. 3). In
adults, the densities of the protectiveWolbachia strainswAu,wRi,
wMel, and wMelPop were significantly higher than that of the
nonprotective wNo strain, providing an association between
Wolbachia density and protection. In contrast, Wolbachia strains
wAu, wRi, and wMel showed lower abundance at the larval stage
than at the adult stage (two-tailed Student’s t test, P 0.05) (Fig.
3A and B), while theWolbachia strainwMelPop showed high den-
sities at both the larval and adult stages (Fig. 3A).Wolbachia den-
sity in the nonprotective N7NO-wNo larvae remained lower than
in either the wRi- or wAu-treated insects at both developmental
stages (Fig. 3B), consistent with a lack of protection.
DISCUSSION
The importance of the route of pathogen entry on the outcome of
infection has beenwell-documented following bacterial infections
in Drosophila. Injecting bacteria into the hemocoel induces a sys-
temic immune response (54–57), while oral infections often lead
to localized immune induction in the gut, often making the bac-
teria less pathogenic (58–60). A recent paper that showed the in-
volvement of the Toll immune pathway inmediating resistance to
oral viral infection with DCV, Flock House virus, cricket paralysis
virus, or Nora virus, however, showed no influence of the viral
exposure pathway following a systemic bacterial infection (37),
indicating that the route of viral entry can have an effect on the
host’s response to viral infection.
We used a natural route of DCV infection, oral feeding, to
investigate the effect of Wolbachia on protection against virus-
inducedmortality, in order to determine whetherWolbachia-me-
diated protection is confined to systemic viral infections in Dro-
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sophila. By examining Wolbachia-mediated protection in adult
flies across four Drosophila-Wolbachia associations that had pre-
viously been shown to be protective following systemic bacterial
infection, we found that oral DCV infections led to a reduction in
virus-induced mortality in adult flies infected with Wolbachia
compared toWolbachia-free flies (Fig. 1). These findings are con-
sistent with a recently published report (37) and support the idea
that Wolbachia-mediated protection extends beyond systemic vi-
ral infections and could be used in future experiments to better
understand the effects of Wolbachia on viral dynamics in natural
insect populations.
While in adults the Wolbachia-mediated reduction in virus-
induced mortality is comparable between systemically and orally
infected flies, the same is not always true in larvae. Of the four
FIG 1 Survival of adult flies following oral challenge with DCV. Each fly strain contained a Wolbachia strain (wol) or was tetracycline treated to remove
Wolbachia (wol). Adult flies were exposed to either homogenates from DCV-infected or mock-infected (PBS) flies for 24 h before being transferred to vials
containing standard cornmeal medium. Survival of flies is shown from 3 biological replicates of 10 flies (or from 1 replicate of 10 flies for PBS controls).
Statistically significant differences in survival were determined by using the log rank test on Kaplan-Meier curves.
Stevanovic et al.
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Drosophila-Wolbachia associations that showed protection fol-
lowing DCV infection in adults, only the w1118-wMelPop flies
showedprotection againstDCV-inducedmortality during the lar-
val stages (Fig. 2E). These results suggest thatWolbachia-mediated
protection may vary between different life stages of the sameDro-
sophila-Wolbachia association, although it is possible that the
amounts of virus ingested by larvae and adults are different. Since
Wolbachia density has previously been shown to be important for
mediating antiviral effects, we measured Wolbachia density in
adults and found that there was congruence between Wolbachia
density and protection against DCV-induced mortality following
the oral route of infection. Similarly to adults, Wolbachia-protec-
tion in larvae was associated with Wolbachia density, however
interestingly highWolbachia density was only observed in w1118-
wMelPop larvae, which was also the only association to show pro-
tection against DCV-induced mortality at the larval stages. The
wMelPop strain causes a life-shortening phenotype and is present
in relatively high densities in both mosquitoes and Drosophila (7,
61–63). The relatively high density and the life-shortening effects
of the wMelPop strain have been reported to be due to the high
copy number of 8 Wolbachia genes referred as the Octomom re-
gion (31, 62). It remains to be seen whether other strains will be
FIG 2 The impact ofWolbachia on virus-induced mortality in DCV-infectedDrosophila larvae. Each fly line was exposed to a differentWolbachia strain or was
tetracycline treated to remove Wolbachia (wol), as indicated on the x axis. Larvae were exposed to homogenates from either DCV-infected or mock-infected
(PBS) flies. Graphs display means and standard errors from three replicates with 100 individuals per fly strain. *, significant interaction (P 0.05) between the
feeding treatment and presence or absence of Wolbachia for mortality.
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protective in larvae and what controls the differences in density
between larvae and adults. The finding that Wolbachia-protec-
tion correlates withWolbachia density is consistent with previous
findings in adult flies following a systemic infection (29–32).
Gradually reducing Wolbachia density in both Drosophila adults
and mosquito cell culture using tetracycline leads to a dose-de-
pendent loss of antiviral protection (12, 30).
Wolbachia-mediated antiviral protection is not limited toDro-
sophila, and since Wolbachia infects up to 40% of all arthropod
species (35) it may be important to consider the impact of life-
stage susceptibility on arthropod population dynamics and viral
transmission. Similarly to Drosophila, mosquitoes also undergo
metamorphosis, a change that can result in life-stage-dependent
differences in viral susceptibility. Mosquitoes are known to form
natural associations with Wolbachia; however, it is artificial
Wolbachia transinfections that have shown promise as a tool for
limiting spread of human pathogenic viruses (5, 6). Commonly,
there is a focus on transmission of arboviruses that occurs between
mosquitoes and human hosts. While this horizontal transmission
is responsible for the major health concerns in humans, vertical
transmission of arboviruses within mosquito populations can af-
fect the maintenance of the virus within the population (64, 65).
Viruses such as dengue virus and Chikungunya virus can be ver-
tically transmitted from an infected adult female to its offspring.
Dengue virus can spread vertically under both natural (66–69)
and laboratory conditions (70–72). Furthermore, transovarially
infected female mosquitoes can transmit dengue virus orally (73).
Chikungunya is also capable of vertical transmission under labo-
ratory conditions, which would suggest that similar transmission
is possible in nature (64).
Various models have been applied to try to understand the
impact of Wolbachia on the transmission of dengue virus in its
mosquito host (74–76). These models do not consider the effects
of vertical transmission on the maintenance of dengue virus
within a population, which has been suggested to be an important
factor affecting the ability of the virus to persist within the popu-
lation in rural areas with low human population densities (65).
Furthermore, vertical transmission could allow the survival of ar-
TABLE 1 Analysis of mortality of Drosophila larvae in response to DCV
in feed with or without Wolbachiaa
Drosophila line and basis of
analysis
Parameter
estimate SE Z score P value
CO
Intercept 0.147 0.116 1.269 0.204
Feeding treatments 0.357 0.166 2.147 0.05
Wolbachia treatments 0.081 0.164 0.492 0.623
Treatment interaction 0.081 0.235 0.343 0.731
Replicate variance
component
0 0
DSR
Intercept 0.134 0.116 1.154 0.249
Feeding treatments 0.53 0.168 3.152 0.01
Wolbachia treatments 0.067 0.164 0.409 0.683
Treatment interaction 0.052 0.237 0.219 0.827
Replicate variance
component
2.4 1011 4.8 106
N7NO
Intercept 0.619 0.121 5.114 0.0001
Feeding treatments 0.41 0.178 2.296 0.05
Wolbachia treatments 0.058 0.17 0.341 0.733
Treatment interaction 0.182 0.254 0.717 0.474
Replicate variance
component
9.7 1015 9.8 108
w1118
Intercept 0.518 0.119 4.339 0.0001
Feeding treatments 0.545 0.178 3.062 0.01
Wolbachia treatments 0.563 0.179 3.154 0.01
Treatment interaction 0.649 0.257 2.522 0.05
Replicate variance
component
5.9 1012 2.4 106
w1118
Intercept 0.504 0.119 4.228 0.0001
Feeding treatments 0.631 0.18 3.51 0.001
Wolbachia treatments 0.101 0.17 0.594 0.553
Treatment interaction 0.137 0.254 0.537 0.591
Replicate variance
component
0 0
a Generalized linear mixed-effects regression (GLMER) analysis of the percent mortality
in five Drosophila lines in response to feeding treatment with PBS or DCV. Each
Drosophila line was either coinfected with a Wolbachia strain (wAu, wRi, wNo,
wMelPop, or wMel) or was not exposed to Wolbachia (wol). Treatment interaction is
a comparison of percent mortality across all combinations of feeding treatment (DCV
or PBS) and the presence/absence of Wolbachia.
FIG 3 The densities of six different Wolbachia strains during larval and adult
stages of development. (A) Relative abundance of the Wolbachia surface pro-
tein gene (wsp) in D. melanogaster, using RpL32 as the reference gene. (B)
Relative abundance of thewsp gene inD. simulans, usingAct5C as the reference
gene.
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boviruses during adverse climatic conditions and has been sug-
gested to be an important mechanism of maintenance of the virus
during interepidemic periods (64). Given the importance of ver-
tical transmission on virus dynamics and the possible life-stage-
dependent variations in Wolbachia-mediated protection, it is im-
portant to consider the impact of Wolbachia antiviral protection,
or the lack of thereof, on the maintenance of a virus within a
population.Understanding the impact ofWolbachia antiviral pro-
tection at different insect life stages is likely to be an important
consideration when designing programs to minimize the spread
of insect-borne viruses.
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